Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality

被引:89
|
作者
Torsney, E
Charlton, R
Diamond, AG
Burn, J
Soames, JV
Arthur, HM [1 ]
机构
[1] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[2] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
关键词
vasculature; angiogenesis; hemorrhage; inflammation;
D O I
10.1161/01.CIR.0000058170.92267.00
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Mutations in endoglin or activin like kinase-1, both involved in the endothelial transforming growth factor-beta signaling pathway, cause the autosomal dominant bleeding disorder hereditary hemorrhagic telangiectasia. We and others have reported mouse models for this disease that share the characteristic phenotype of dilated vessels and sporadic hemorrhage. The reasons for the variable phenotype in hereditary hemorrhagic telangiectasia are not understood. Methods and Results-After a detailed immunohistochemical analysis of 129/Ola mice, which are heterozygous for a targeted deletion in the endoglin gene, we observed intrinsic abnormalities in the vascular walls throughout the cutaneous vasculature. Postcapillary venules were dilated, and up to 70% of the vascular wall had no smooth muscle cells. The supporting layers of collagens and elastin were irregular, with thin areas, adding to the fragility of these vessels. A variable hemorrhagic phenotype was observed in which local bleeding is associated not only with fragile vessels but also with regions of inflammation. Conclusions-These findings have relevance to our understanding of the molecular basis of vascular integrity in a wide range of diseases.
引用
收藏
页码:1653 / 1657
页数:5
相关论文
共 50 条
  • [21] Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era?
    Cerrone, Antonio
    Buscarini, Elisabetta
    Berte, Roberto
    Alicante, Saverio
    Bertolazzi, Stefania
    Moreschi, Olivia
    Griffanti, Paola
    Manfredi, Guido
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2025, 51 (01) : 91 - 97
  • [22] Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19
    Antoni Riera-Mestre
    Adriana Iriarte
    Manuela Moreno
    Raul del Castillo
    Daniel López-Wolf
    Angiogenesis, 2021, 24 : 13 - 15
  • [23] Non-Coding RNAs and Hereditary Hemorrhagic Telangiectasia
    Cannavicci, Anthony
    Zhang, Qiuwang
    Kutryk, Michael J. B.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 14
  • [24] Epidemiology and Trends of Hereditary Hemorrhagic Telangiectasia in the United States
    Ferry, Andrew M.
    Wright, Alex E.
    Baillargeon, Gwen
    Kuo, Yong-Fang
    Chaaban, Mohamad R.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2020, 34 (02) : 230 - 237
  • [25] Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia
    Sugden, Wade W.
    Siekmann, Arndt F.
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (03) : 237 - 244
  • [26] Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
    Gallardo-Vara, Eunate
    Tual-Chalot, Simon
    Botella, Luisa M.
    Arthur, Helen M.
    Bernabeu, Carmelo
    DISEASE MODELS & MECHANISMS, 2018, 11 (09)
  • [27] A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10
    Ruiz, Santiago
    Zhao, Haitian
    Chandakkar, Pallavi
    Chatterjee, Prodyot K.
    Papoin, Julien
    Blanc, Lionel
    Metz, Christine N.
    Campagne, Fabien
    Marambaud, Philippe
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Therapeutic targeting of vascular malformation in a zebrafish model of hereditary haemorrhagic telangiectasia
    Snodgrass, Ryan O.
    Govindpani, Karan
    Plant, Karen
    Kugler, Elisabeth C.
    Doh, Changmin
    Dawson, Thomas
    McCormack, Luis E.
    Arthur, Helen M.
    Chico, Timothy J. A.
    DISEASE MODELS & MECHANISMS, 2023, 16 (04)
  • [29] Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management
    Viteri-Noel, Adrian
    Gonzalez-Garcia, Andres
    Patier, Jose Luis
    Fabregate, Martin
    Bara-Ledesma, Nuria
    Lopez-Rodriguez, Monica
    del Olmo, Vicente Gomez
    Manzano, Luis
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [30] Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1
    Galaris, Georgios
    Montagne, Kevin
    Thalgott, Jeremy H.
    Goujon, Geoffroy J. P. E.
    van den Driesche, Sander
    Martin, Sabrina
    Mager, Hans-Jurgen J.
    Mummery, Christine L.
    Rabelink, Ton J.
    Lebrin, Franck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)